Ankiti Bose and the New Longevity Economy: From Terra-Invest to AI-Powered Preventive Healthcare

Ankiti Bose is building her next chapter at the intersection of capital, technology, preventive healthcare, longevity and emerging markets. As one of the Founding Partners of Terra-Invest and Chairperson of Terra’s Future Health Group, Bose is increasingly focused on one of the most important shifts in global healthcare: the move from reactive treatment to predictive, personalised and preventive health.

Her work today spans energy transition, healthcare, finance, technology, strategic capital platforms, pre-IPO opportunities and AI-powered consumer health. But one of the clearest themes in Bose’s current portfolio is longevity, not as a luxury wellness trend, but as a new healthcare category built around diagnostics, data, artificial intelligence, performance health and long-term human vitality.

From Founder to Investor-Operator

Ankiti Bose first became known as a technology entrepreneur in Asia, where she co-founded a large-scale e-commerce company focused on the fashion and supply-chain industry. That journey exposed her to the speed, complexity and pressure of building across emerging markets.

Today, her work has evolved from consumer internet and supply chains into a broader investment and operating thesis through Terra-Invest. At Terra-Invest, Bose focuses on sectors where capital, governance, policy, technology and real-world demand intersect.

This includes energy transition, healthcare finance, technology platforms, trade finance, strategic capital initiatives and pre-IPO opportunities. The unifying thread is her interest in businesses that can move from niche to category-defining, especially in markets where structural demand is rising. It is a thesis explored in more detail in our profile of Ankiti Bose’s work across Terra-Invest and Terra’s Future Health Group.

Why Longevity Is Central to Ankiti Bose’s Current Work

Longevity has become one of the most important emerging categories in healthcare and consumer health. For Ankiti Bose, longevity is not simply about anti-ageing. It is about building a more intelligent healthcare system, one that detects risk earlier, personalises intervention and helps people live better for longer.

Through Terra’s Future Health Group, Bose is involved in platforms that operate and invest across AI-led diagnostics, precision medicine, telehealth, longevity clinics, regenerative wellness, aesthetics, performance health and next-generation health optimisation.

The group is built around a simple belief: the future of healthcare will be predictive, personalised, preventive and performance-led.

This reflects a much larger shift in healthcare. Patients are no longer waiting passively for illness. Increasingly, consumers want to understand their biomarkers, hormones, inflammation, metabolic health, cognitive performance, biological age and long-term risk profile before disease appears.

Terra’s Future Health Group and AI Healthcare

Terra’s Future Health Group sits at the intersection of longevity, AI healthcare and consumer health. The platform invests in and manages AI-powered longevity, aesthetics and health optimisation platforms and clinics across the Middle East and Europe.

Its work spans several fast-growing areas of modern healthcare, including:

• AI-led diagnostics that help identify health signals earlier and more precisely.
• Precision medicine that uses data, testing and biomarkers to personalise health interventions.
• Telehealth and homecare that make advanced healthcare more accessible and continuous.
• Longevity clinics focused on healthspan, performance, prevention and optimisation.
• Regenerative wellness and aesthetics for patients seeking vitality, confidence and better ageing outcomes.

For Bose, the opportunity is not only clinical. It is also structural. The next generation of healthcare companies will likely combine medical credibility, consumer trust, technology infrastructure, data, brand and capital.

The Rise of Preventive Healthcare in the Middle East

The Middle East is becoming an important region for the future of longevity and preventive healthcare. Countries such as the UAE are investing heavily in healthcare innovation, medical tourism, digital health, AI adoption and premium consumer wellness.

This creates a strong environment for platforms focused on longevity clinics, diagnostics and aesthetics, regenerative medicine, telehealth and health optimisation.

Ankiti Bose’s work through Terra’s Future Health Group reflects this regional opportunity. The Middle East has the capital, consumer demand, healthcare ambition and policy momentum to become a global hub for AI-powered preventive health, a shift also visible in the growth of Gulf medical and wellness tourism.

For patients, this means access to more advanced diagnostics, personalised protocols and a new model of healthcare focused on healthspan rather than only disease treatment.

A Personal Longevity Journey

Ankiti Bose’s interest in longevity is also personal. Her own longevity journey began in her 30s after years of high-pressure building, operating, media scrutiny and work stress.

That experience led her into deep diagnostics, peptides, cognitive training, neuroscience, stem cells, exosomes, hormone optimisation and other cutting-edge protocols across California, Switzerland and the UAE.

According to her public profile, Bose has often chosen to be the first patient within the group, testing protocols, tracking biomarkers and learning firsthand how science, data and disciplined intervention can shape healthspan. Through this journey, she has slowed her measured pace of ageing to 0.77x and brought several biological-age markers to around 28.

This personal experience gives her a patient-founder lens on the longevity industry. It also reflects a growing truth about the category: the most compelling healthcare founders are often those who have lived the problem deeply.

AI, Diagnostics and the Future of Healthspan

One of the most important ideas behind Ankiti Bose’s longevity work is that health optimisation must become more measurable.

The future of longevity will not be built only on supplements, spa treatments or generic wellness advice. It will be built on biomarkers, diagnostics, AI models, clinical protocols, longitudinal data and personalised care.

This is where artificial intelligence becomes important. AI can help health platforms analyse patterns across diagnostics, lifestyle, symptoms, biological age, blood work, hormones, sleep, stress, metabolic health and treatment response.

For consumers, this means healthcare can become more continuous and proactive. For investors and operators, it means a new category of companies can emerge at the convergence of healthcare, data, AI, clinics, consumer trust and medical science.

Beyond Healthcare: Terra-Invest and Frontier Markets

While longevity is an increasingly important part of Ankiti Bose’s work, her broader focus through Terra-Invest remains multi-sector.

Terra-Invest operates across themes including energy transition, finance, technology, healthcare, trade finance, strategic capital platforms and pre-IPO opportunities. These sectors may appear different on the surface, but they share a common logic: each sits within a long-term structural shift.

Energy transition is reshaping infrastructure and industrial policy. AI is reshaping productivity and healthcare. Preventive medicine is reshaping consumer health. Pre-IPO opportunities are reshaping access to growth companies. Emerging markets are reshaping where the next generation of demand will come from.

Bose’s work sits across these shifts, with a particular focus on where capital and execution can turn macro themes into operating platforms.

AI Education and Bharat Udyam AI Foundation

More recently, Ankiti Bose has also started working closely with local lawmakers and young people in India through the Bharat Udyam AI Foundation, supporting grassroots AI education, entrepreneurship and future-skills access.

This work reflects another important part of her thesis: artificial intelligence should not remain concentrated in elite technology circles. For young people in India, AI education can become a pathway to entrepreneurship, employability, productivity and economic mobility.

By connecting AI education with grassroots access, Bharat Udyam AI Foundation sits within a broader movement to democratise future skills for India’s next generation.

Why Ankiti Bose’s Next Chapter Matters

Ankiti Bose’s current chapter is important because it reflects the direction of several global sectors at once.

Healthcare is becoming more preventive. Longevity is becoming more mainstream. AI is becoming more embedded in diagnostics and decision-making. Consumers are becoming more sophisticated about biomarkers, healthspan, aesthetics and performance. Emerging markets are becoming more central to global growth.

Through Terra-Invest and Terra’s Future Health Group, Bose is positioning herself at the convergence of these shifts.

Her current work is not only about investing in companies. It is about building platforms for a future in which healthcare becomes more intelligent, capital becomes more strategic and consumers expect more from their health systems.

Who Is Ankiti Bose Today?

Today, Ankiti Bose is best understood as a Terra-Invest founding partner, longevity investor, AI healthcare builder and emerging-markets operator.

Her work spans capital, technology, preventive healthcare, AI-led diagnostics, longevity clinics, aesthetics, energy transition, finance and frontier markets.

From Terra-Invest to Terra’s Future Health Group, Bose’s current focus is clear: building and backing companies that sit at the convergence of science, capital, technology, governance and consumer trust.

At the heart of her work is a simple idea: the future of healthcare will not only treat disease. It will help people understand, optimise and extend their healthspan before disease begins.

FAQ

What is Terra’s Future Health Group?

It is the health platform Ankiti Bose chairs, investing in and managing AI-powered longevity, aesthetics and health optimisation clinics and platforms across the Middle East and Europe, built around predictive, personalised and preventive care.

How is Ankiti Bose involved in longevity?

She invests in and builds longevity and preventive-health platforms through Terra’s Future Health Group, and follows the category personally, tracking biomarkers and protocols as an early patient within the group.

What does Terra-Invest focus on?

Terra-Invest works across energy transition, healthcare, finance, technology, trade finance, strategic capital platforms and pre-IPO opportunities, with a focus on long-term structural shifts in emerging and global markets.